Hi all holders, a lot of posts overtime suggest that Big Pharmo's will do whatever to prevent losing market share of its products, and I am sure it happens all the time, but the fact there is no other treatment for children with GvHD surely would mean that they have no financial reasons to hinder MSB going fwd, and the timely announcement by the FDA was in no means an effort to derail MSB, although what is has done is produced a massive tremor that caused many investors to fall from the tree. One has to think who is buying all those fallen leaves.
Howie
MSB Trading - Aug 2020 on, page-1288
-
- There are more pages in this discussion • 1,097 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.06 |
Change
0.030(2.91%) |
Mkt cap ! $1.210B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.09 | $1.03 | $5.796M | 5.430M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15990 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 48632 | 3 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |